Shuttle Pharmaceuticals Inc (SHPH): Prediction

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	31
Posts	2583
Boards Moderated	0
Alias Born	02/18/2005

threebabiesbusy

Re: threebabiesbusy post# 121

Wednesday, 11/02/2022 8:12:13 PM

Wednesday, November 02, 2022 8:12:13 PM

Prediction - .33

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent SHPH News

Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 01:00:15 PM
Shuttle Pharma Appoints Timothy Lorber as Chief Financial Officer • GlobeNewswire Inc. • 06/18/2024 01:00:00 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 06/10/2024 10:12:20 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2024 08:15:20 PM
Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 • GlobeNewswire Inc. • 05/22/2024 08:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 01:00:22 PM
Shuttle Pharma Provides First Quarter 2024 Corporate Update • GlobeNewswire Inc. • 05/14/2024 01:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 09:01:59 PM
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024 • GlobeNewswire Inc. • 04/23/2024 08:15:00 PM
Shuttle Pharma Provides Fourth Quarter 2023 Corporate Update • PR Newswire (US) • 03/22/2024 01:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 11:18:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 02:00:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:00:16 PM
Shuttle Pharma Announces Its Intent to Pursue a Rights Offering • PR Newswire (US) • 02/13/2024 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:25:13 PM
Shuttle Pharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024 • PR Newswire (US) • 01/23/2024 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 02:05:10 PM
Shuttle Pharmaceuticals Receives FDA Approval to Proceed with Phase II Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma • PR Newswire (US) • 01/08/2024 02:00:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 10:10:30 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/21/2023 02:51:28 AM
Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2023 10:10:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 02:00:12 PM
Shuttle Pharmaceuticals Submits IND Application to the U.S. FDA for Ropidoxuridine Phase II Clinical Trial for Patients with Glioblastoma • PR Newswire (US) • 12/11/2023 02:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 02:00:25 PM
Shuttle Pharmaceuticals Provides Third Quarter 2023 Corporate Update • PR Newswire (US) • 11/14/2023 02:00:00 PM

More SHPH News

InvestorsHub NewsWire

FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM

HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM

Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM

ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM

Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM

Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover